Time to be positive about negative data?
作者信息
Vincent T, Malfait A-M
机构信息
Arthritis Research UK Centre for OA Pathogenesis, Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Oxford OX3 7FY, UK.
Department of Internal Medicine, Division of Rheumatology & Department of Biochemistry, Rush University Medical Center, 1611 W. Harrison St, Suite 510, Chicago, IL 60612, USA.
出版信息
Osteoarthritis Cartilage. 2017 Mar;25(3):351-353. doi: 10.1016/j.joca.2017.01.016.
Abstract
摘要
相似文献
1
Time to be positive about negative data?是时候对负面数据持积极态度了？
Osteoarthritis Cartilage. 2017 Mar;25(3):351-353. doi: 10.1016/j.joca.2017.01.016.
2
[The dance about the "impact factor"].关于“影响因子”的闹剧
Ugeskr Laeger. 2007 Jun 11;169(24):2317.
3
[The profit roundabout].[利润循环]
Tidsskr Nor Laegeforen. 2007 May 3;127(9):1173.
4
[Clinical medical research--from wrong to worse?].[临床医学研究——每况愈下？]
Tidsskr Nor Laegeforen. 2003 Jan 23;123(2):142.
5
Assessment of publication bias for the surgeon scientist.对外科医生科学家发表偏倚的评估。
Br J Surg. 2008 Aug;95(8):943-9. doi: 10.1002/bjs.6302.
6
Uptake of methods to deal with publication bias in systematic reviews has increased over time, but there is still much scope for improvement.随着时间的推移，系统评价中处理发表偏倚的方法的采用率有所提高，但仍有很大的改进空间。
J Clin Epidemiol. 2011 Apr;64(4):349-57. doi: 10.1016/j.jclinepi.2010.04.022.
7
Publication bias as a function of study characteristics.发表偏倚的研究特征函数。
Psychol Methods. 2015 Sep;20(3):310-30. doi: 10.1037/met0000046.
8
Null is beautiful: On the importance of publishing null results.“零结果”亦有其美：论发表零结果的重要性。
J Psychopharmacol. 2016 Jul;30(7):585. doi: 10.1177/0269881116638813.
9
Publication bias in the anesthesiology literature.麻醉学文献中的发表偏倚。
Anesth Analg. 2012 May;114(5):1042-8. doi: 10.1213/ANE.0b013e3182468fc6. Epub 2012 Feb 17.
10
Conflicts of interest may bias research into sugary drinks and obesity.利益冲突可能会使关于含糖饮料与肥胖的研究产生偏差。
BMJ. 2014 Jan 2;348:f7654. doi: 10.1136/bmj.f7654.
引用本文的文献
1
Effects of Terpenes on the Osteoarthritis Cytokine Profile by Modulation of IL-6: Double Face versus Dark Knight?萜类化合物通过调节白细胞介素-6对骨关节炎细胞因子谱的影响：双面还是黑暗骑士？
Biology (Basel). 2023 Jul 28;12(8):1061. doi: 10.3390/biology12081061.
2
Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developments.骨关节炎药物干预的挑战与机遇：当前临床试验及进展综述
Osteoarthr Cartil Open. 2021 Sep 8;3(4):100212. doi: 10.1016/j.ocarto.2021.100212. eCollection 2021 Dec.
3
Of mice and men: converging on a common molecular understanding of osteoarthritis.从鼠到人：对骨关节炎达成共同的分子层面理解
Lancet Rheumatol. 2020 Oct;2(10):e633-e645. doi: 10.1016/S2665-9913(20)30279-4. Epub 2020 Sep 23.
4
Molecular and structural imaging in surgically induced murine osteoarthritis.手术诱导的小鼠骨关节炎的分子和结构影像学。
Osteoarthritis Cartilage. 2020 Jul;28(7):874-884. doi: 10.1016/j.joca.2020.03.016. Epub 2020 Apr 16.
5
IL-1 in osteoarthritis: time for a critical review of the literature.白细胞介素-1在骨关节炎中的作用：对相关文献进行批判性综述的时候了。
F1000Res. 2019 Jun 21;8. doi: 10.12688/f1000research.18831.1. eCollection 2019.
本文引用的文献
1
Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.C-C趋化因子受体2在损伤诱导的小鼠骨关节炎模型中的作用
Osteoarthritis Cartilage. 2017 Jun;25(6):914-925. doi: 10.1016/j.joca.2016.11.004. Epub 2016 Nov 14.
2
Considerations for the design and execution of protocols for animal research and treatment to improve reproducibility and standardization: "DEPART well-prepared and ARRIVE safely".提高动物研究和治疗方案的可重复性和标准化的设计与实施考量：“充分准备出发，安全抵达”。
Osteoarthritis Cartilage. 2017 Mar;25(3):354-363. doi: 10.1016/j.joca.2016.10.016. Epub 2016 Nov 2.
3
CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy.CCL2和CCR2调节创伤后小鼠骨关节炎中与疼痛相关的行为和早期基因表达，但对软骨病的影响很小。
Osteoarthritis Cartilage. 2017 Mar;25(3):406-412. doi: 10.1016/j.joca.2016.10.008. Epub 2016 Oct 13.
4
Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.白细胞介素-1不参与胶原酶诱导的骨关节炎中的滑膜炎症和软骨破坏。
Osteoarthritis Cartilage. 2017 Mar;25(3):385-396. doi: 10.1016/j.joca.2016.09.009. Epub 2016 Sep 18.
5
Considerations for the design, analysis and presentation of in vivo studies.体内研究的设计、分析与呈现的考量因素
Osteoarthritis Cartilage. 2017 Mar;25(3):364-368. doi: 10.1016/j.joca.2016.06.023. Epub 2016 Jul 30.
6
Upregulation of Atrogin-1/FBXO32 is not necessary for cartilage destruction in mouse models of osteoarthritis.在骨关节炎小鼠模型中，Atrogin-1/FBXO32的上调对于软骨破坏并非必需。
Osteoarthritis Cartilage. 2017 Mar;25(3):397-400. doi: 10.1016/j.joca.2016.07.008. Epub 2016 Jul 30.
7
Upregulation of lipocalin-2 (LCN2) in osteoarthritic cartilage is not necessary for cartilage destruction in mice.骨关节炎软骨中脂质运载蛋白-2（LCN2）的上调对于小鼠软骨破坏并非必要。
Osteoarthritis Cartilage. 2017 Mar;25(3):401-405. doi: 10.1016/j.joca.2016.07.009. Epub 2016 Jul 29.
8
ADAMTS-5 takes centre stage in new developments for aggrecanase inhibitors.ADAMTS-5在聚集蛋白聚糖酶抑制剂的新进展中占据核心地位。
Osteoarthritis Cartilage. 2015 Aug;23(8):1231-2. doi: 10.1016/j.joca.2015.05.023. Epub 2015 May 28.
9
Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice.在小鼠手术诱导的骨关节炎模型中，环氧化酶2抑制缺乏软骨保护作用。
Arthritis Rheum. 2012 Jan;64(1):198-203. doi: 10.1002/art.33324.
10
Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis.在小鼠中对ADAMTS - 4和ADAMTS - 5进行双敲除可产生生理上正常的动物，并阻止骨关节炎的进展。
Arthritis Rheum. 2007 Nov;56(11):3670-4. doi: 10.1002/art.23027.
Zotero 插件